THIOVALONE, suspension for spraying oromucosal bottle, 12 ml
Active ingredients: Chlorhexidine gluconate, Tixocortol pivalate, SOLUTION DE DIGLUCONATE DE CHLORHEXIDINE
Commercialized according to BDPM
Suspension for sprayingbottle, 12 mlvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THIOVALONE, suspension pour pulvérisation buccale
- Pharmaceutical form
- suspension pour pulvérisation
- Route of administration
- voie buccale autre
- Presentation description
- 1 flacon(s) polyéthylène de 12 ml avec pompe doseuse et embout buccal
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Feb 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65124483CIP73465366CIP133400934653667Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIVALATE DE TIXOCORTOLsuspension | 0,333 g · 100 ml | SA |
| DIGLUCONATE DE CHLORHEXIDINEsuspension | 0,143 g · 100 ml | FT |
| SOLUTION DE DIGLUCONATE DE CHLORHEXIDINEsuspension | 0,760 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.